STAA Q1 2023 Earnings — STAAR Surgical Company Revenue & Financial Results | Market Cap Arena

STAASTAAR Surgical Company

$860M

Q1 2023 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$74M+16.3% YoY

Gross Profit

$58M78.3% margin

Operating Income

$3M3.8% margin

Net Income

$3M3.7% margin

EPS (Diluted)

$0.05

QoQ Revenue Growth

+14.8%

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$8M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$419M

Total Liabilities

$80M

Stockholders' Equity

$339M

Cash & Equivalents

$90M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$74M	$63M	+16.3%
Gross Profit	$58M	$49M	+16.8%
Operating Income	$3M	$12M	-76.9%
Net Income	$3M	$10M	-71.8%

Revenue Segments

Implantable Collamer Lenses

$71M96%

Cataract Intraocular Lenses

$1M2%

Other Surgical Products

$1M2%